NCT05306249View on ClinicalTrials.gov

Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 16, 2022

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
HIV Seropositivity
Interventions
DRUG

CBD LGP 50

Patients will receive CBD LGP 50 at a dose of 1 mg/kg twice a day in the form of oil dispensed through a graduated pipette until the end of week 12.

DRUG

Placebo

Patients will receive the MCT oil placebo without CBD until the end of week 12.

Trial Locations (1)

45000

Centre Hospitalier Régional d'Orléans, France, Orléans

All Listed Sponsors
lead

Centre Hospitalier Régional d'Orléans

OTHER